Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blinatumomab to improve the outcome of children with relapsed B-cell acute lymphoblastic leukemia.
Fuster JL, Bautista F, González B, Fernández JM, Rives S, Dapena JL; Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP). Fuster JL, et al. Among authors: rives s. Clin Transl Oncol. 2021 Sep;23(9):1963-1966. doi: 10.1007/s12094-021-02590-0. Epub 2021 Mar 19. Clin Transl Oncol. 2021. PMID: 33742341 No abstract available.
High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.
Carrillo J, Martínez P, Solera J, Moratilla C, González A, Manguán-García C, Aymerich M, Canal L, Del Campo M, Dapena JL, Escoda L, García-Sagredo JM, Martín-Sala S, Rives S, Sevilla J, Sastre L, Perona R. Carrillo J, et al. Among authors: rives s. Blood Cells Mol Dis. 2012 Oct 15-Dec 15;49(3-4):140-6. doi: 10.1016/j.bcmd.2012.05.008. Epub 2012 Jun 2. Blood Cells Mol Dis. 2012. PMID: 22664374
Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening.
Berrueco R, Alonso-Saladrigues A, Martorell-Sampol L, Català-Temprano A, Ruiz-Llobet A, Toll T, Torrebadell M, Naudó M, Camós M, Rives S. Berrueco R, et al. Among authors: rives s. Pediatr Blood Cancer. 2015 Jul;62(7):1195-201. doi: 10.1002/pbc.25457. Epub 2015 Apr 8. Pediatr Blood Cancer. 2015. PMID: 25855413
Landscape of early clinical trials for childhood and adolescence cancer in Spain.
Bautista F, Gallego S, Cañete A, Mora J, Diaz de Heredia C, Cruz O, Fernández JM, Rives S, Madero L, Castel V, Cela ME, Ramírez G, Sábado C, Acha T, Astigarraga I, Sastre A, Muñoz A, Guibelalde M, Moreno L. Bautista F, et al. Among authors: rives s. Clin Transl Oncol. 2016 Jul;18(7):708-13. doi: 10.1007/s12094-015-1421-9. Epub 2015 Oct 21. Clin Transl Oncol. 2016. PMID: 26489424
Asparaginase use for the treatment of acute lymphoblastic leukemia.
Barba P, Dapena JL, Montesinos P, Rives S. Barba P, et al. Among authors: rives s. Med Clin (Barc). 2017 Mar 3;148(5):225-231. doi: 10.1016/j.medcli.2016.12.006. Epub 2017 Jan 22. Med Clin (Barc). 2017. PMID: 28118965 Review. English, Spanish. No abstract available.
[Early clinical trials in paediatric oncology in Spain: a nationwide perspective].
Bautista F, Gallego S, Cañete A, Mora J, Díaz de Heredia C, Cruz O, Fernández JM, Rives S, Berlanga P, Hladun R, Juan Ribelles A, Madero L, Ramírez M, Fernández Delgado R, Pérez-Martínez A, Mata C, Llort A, Martín Broto J, Cela ME, Ramírez G, Sábado C, Acha T, Astigarraga I, Sastre A, Muñoz A, Guibelalde M, Moreno L; en nombre de la Sociedad Española de Oncología Pediátrica (SEHOP) y el Grupo de Nuevas Terapias en Oncología Pediátrica; Sociedad Española de Hematología y Oncología Pediátrica (SEHOP) and the New Drug Development Group in Pediatric Oncology. Bautista F, et al. Among authors: rives s. An Pediatr (Barc). 2017 Sep;87(3):155-163. doi: 10.1016/j.anpedi.2016.07.007. Epub 2017 Mar 6. An Pediatr (Barc). 2017. PMID: 28279690 Free article. Spanish.
ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain.
Bautista F, Cañete A, Ramírez-Villar GL, Fernández JM, Fuster JL, Diaz de Heredia C, Astigarraga I, García-Ariza M, Rives S, Dapena JL, Márquez C, Molinés A, Bermúdez MDM, Gallego S, Andrés MDM, Verdu-Amoros J, Hernández C, López M, Catalá A, Lassaletta Á, Cruz O, Ramírez M, Lendínez F, Carboné A, Gomez Sirvent J, Tallón M, Acha T, Moreno L, Fernández-Teijeiro A; Sociedad Española de Hematología y Oncología Pediátrica (SEHOP). Bautista F, et al. Among authors: rives s. Clin Transl Oncol. 2019 Dec;21(12):1763-1770. doi: 10.1007/s12094-019-02221-9. Epub 2019 Oct 9. Clin Transl Oncol. 2019. PMID: 31598904 Free article.
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial.
Laetsch TW, Myers GD, Baruchel A, Dietz AC, Pulsipher MA, Bittencourt H, Buechner J, De Moerloose B, Davis KL, Nemecek E, Driscoll T, Mechinaud F, Boissel N, Rives S, Bader P, Peters C, Sabnis HS, Grupp SA, Yanik GA, Hiramatsu H, Stefanski HE, Rasouliyan L, Yi L, Shah S, Zhang J, Harris AC. Laetsch TW, et al. Among authors: rives s. Lancet Oncol. 2019 Dec;20(12):1710-1718. doi: 10.1016/S1470-2045(19)30493-0. Epub 2019 Oct 9. Lancet Oncol. 2019. PMID: 31606419 Free PMC article. Clinical Trial.
[Immunotherapy with CAR-T cells in paediatric haematology-oncology].
Mirones I, Moreno L, Patiño-García A, Lizeaga G, Moraleda JM, Toribio ML, Pérez-Martínez A; Grupo de Inmunoterapia y Terapias Avanzadas de la Sociedad Española de Hematología y Oncología Pediátricas; Grupo de Inmunoterapia y Terapias Avanzadas de la Sociedad Española de Hematología y Oncología Pediátricas. Mirones I, et al. An Pediatr (Engl Ed). 2020 Jul;93(1):59.e1-59.e10. doi: 10.1016/j.anpedi.2019.12.014. Epub 2020 Feb 24. An Pediatr (Engl Ed). 2020. PMID: 32107177 Free article. Spanish.
125 results